Abstract
Background & Objectives Characterizing the progression of coronary atherosclerosis is a critical public health goal. The most common quantitative summary, the CAC score, is modelled by a variety of statistical methods, both as a predictor of coronary events and as an outcome of behavioral and population-specific risk factors. Little attempt has been made, however, to ground these statistical models in the underlying physiology of arterial aging, which would allow us to describe the onset and growth of CAC over a patient's life.
Methods Using a generative growth model for arterial plaque accumulation, we identify severe under-estimation in the age of initial onset and rate of progression (doubling time) of CAC growth with standard ln(CAC + 1) or ln(CAC | CAC > 0) models, and use this growth model to motivate new statistical approaches to CAC using logistic and log-linear mixture regressions. We compare statistical models directly by computing their average parameter biases using 540 growth trajectory simulations (113,760 patients, 268,200 observations).
Results While all models used can successfully estimate the influence of risk factors with minimal bias, we demonstrate substantial improvements in predictive accuracy in the timing of CAC onset and progression with logistic regression and linked hurdle-lognormal mixture regression, compared with standard ln(CAC + 1) or ln(CAC | CAC > 0) models.
Conclusions Using models that can account for patient-specific onset and progression rates, accurate descriptions of CAC trajectories can be made even in cross-sectional (single scan per patient) designs, with substantial clinical and epidemiological utility.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This paper uses clinical simulation data to validate statistical models of atherosclerosis, and involves no participants.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All statistical models and simulation data and software are available in the following github repository.
